| ²é¿´: 332 | »Ø¸´: 1 | ||
·±»ªÂåÂåÌú³æ (ÕýʽдÊÖ)
|
[ÇóÖú]
10.1016/j.bmcl.2010.03.084ÇóÖú´ËƪÎÄÏ×µÄ֪ʶÐÅÏ¢£¬Ð»Ð»
|
|
ÌâÄ¿£ºSynthesis and biological evaluation of 1,4-diazepane derivatives as T-typecalcium channel blockers 10.1016/j.bmcl.2010.03.084 ÇóÖú´ËƪÎÄÏ×µÄ֪ʶÐÅÏ¢£¬Ð»Ð» |
» ²ÂÄãϲ»¶
²ÄÁÏÓ뻯¹¤£¨0856£©304Çó BÇø µ÷¼Á
ÒѾÓÐ3È˻ظ´
268Çóµ÷¼Á
ÒѾÓÐ8È˻ظ´
265Çóµ÷¼Á
ÒѾÓÐ14È˻ظ´
350 ±¾¿Æ985Çóµ÷¼Á£¬ÇóÀϵÇÊÕÁô
ÒѾÓÐ3È˻ظ´
¡¾¿¼Ñе÷¼Á¡¿»¯Ñ§×¨Òµ 281·Ö£¬Ò»Ö¾Ô¸ËÄ´¨´óѧ£¬³ÏÐÄÇóµ÷¼Á
ÒѾÓÐ9È˻ظ´
³õÊÔ 317
ÒѾÓÐ3È˻ظ´
279·ÖÇóµ÷¼Á Ò»Ö¾Ô¸211
ÒѾÓÐ15È˻ظ´
286Çóµ÷¼Á
ÒѾÓÐ4È˻ظ´
279Çóµ÷¼Á
ÒѾÓÐ4È˻ظ´
Çóµ÷¼Á
ÒѾÓÐ3È˻ظ´
lyd186568
°æÖ÷ (Ö°Òµ×÷¼Ò)
Îá±¾Ò»ÏÐÈË
- Ó¦Öú: 64 (³õÖÐÉú)
- ¹ó±ö: 6.727
- ½ð±Ò: 43468.5
- É¢½ð: 2085
- ºì»¨: 80
- ɳ·¢: 5
- Ìû×Ó: 4788
- ÔÚÏß: 1429.9Сʱ
- ³æºÅ: 4813211
- ×¢²á: 2016-07-03
- ÐÔ±ð: GG
- רҵ: ÆäËûÎÞ»ú·Ç½ðÊô²ÄÁÏ
- ¹ÜϽ: ÍâÎÄÊé¼®ÇóÖú
¡¾´ð°¸¡¿Ó¦Öú»ØÌû
¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï
¸Ðл²ÎÓ룬ӦÖúÖ¸Êý +1
·±»ªÂåÂå: ½ð±Ò+15, ¡ïÓаïÖú 2018-12-07 09:37:06
¸Ðл²ÎÓ룬ӦÖúÖ¸Êý +1
·±»ªÂåÂå: ½ð±Ò+15, ¡ïÓаïÖú 2018-12-07 09:37:06
|
Synthesis and biological evaluation of 1,4-diazepane derivatives as T-type calcium channel blockers ×÷Õß:Gu, SJ (Gu, Su Jin)[ 1,2 ] ; Lee, JK (Lee, Jae Kyun)[ 1 ] ; Pae, AN (Pae, Ae Nim)[ 1 ] ; Chung, HJ (Chung, Hye Jin)[ 1 ] ; Rhim, H (Rhim, Hyewon)[ 1 ] ; Han, SY (Han, So Yeob)[ 2 ] ; Min, SJ (Min, Sun-Joon)[ 1 ] ; Cho, YS (Cho, Yong Seo)[ 1 ] ²é¿´ ResearcherID ºÍ ORCID BIOORGANIC & MEDICINAL CHEMISTRY LETTERS ¾í: 20 ÆÚ: 9 Ò³: 2705-2708 DOI: 10.1016/j.bmcl.2010.03.084 ³ö°æÄê: MAY 1 2010 ÎÄÏ×ÀàÐÍ:Article ²é¿´ÆÚ¿¯Ó°ÏìÁ¦ ÕªÒª We have synthesized and biologically evaluated 1,4-diazepane derivatives as T-type calcium channel blockers. In this study, we discovered compound 4s, a potential T-type calcium channel blocker with good selectivity over hERG and N-type calcium channels. In addition, it exhibited favorable pharmacokinetic characteristics for further investigation of T-type calcium channel related diseases. (C) 2010 Elsevier Ltd. All rights reserved. ¹Ø¼ü´Ê ×÷Õ߹ؼü´Ê:T-type calcium channel blockers; 1,4-Diazepane; Pharmacokinetics KeyWords Plus:CA2+ CHANNELS; DESIGN; ANTAGONISTS; MIBEFRADIL; DISCOVERY ×÷ÕßÐÅÏ¢ ͨѶ×÷ÕßµØÖ·: Min, SJ (ͨѶ×÷Õß) ÏÔʾ¸ü¶à Korea Inst Sci & Technol, Life Hlth Div, POB 131, Seoul 130650, South Korea. µØÖ·: ÏÔʾ¸ü¶à [ 1 ] Korea Inst Sci & Technol, Life Hlth Div, Seoul 130650, South Korea ÏÔʾ¸ü¶à [ 2 ] Ewha Womans Univ, Dept Chem & Nano Sci, Seoul 130701, South Korea µç×ÓÓʼþµØÖ·:sjmin@kist.re.kr; ys4049@kist.re.kr »ù½ð×ÊÖúÖÂл »ù½ð×ÊÖú»ú¹¹ ÊÚȨºÅ KIST 2E21010 ²é¿´»ù½ð×ÊÖúÐÅÏ¢ ³ö°æÉÌ PERGAMON-ELSEVIER SCIENCE LTD, THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND ÆÚ¿¯ÐÅÏ¢ Impact Factor (Ó°ÏìÒò×Ó): Journal Citation Reports Àà±ð / ·ÖÀà Ñо¿·½Ïò harmacology & Pharmacy; ChemistryWeb of Science Àà±ð:Chemistry, Medicinal; Chemistry, Organic ÎÄÏ×ÐÅÏ¢ ÓïÑÔ:English Èë²ØºÅ: WOS:000276816600001 PubMed ID: 20382529 ISSN: 0960-894X eISSN: 1464-3405 ÆäËûÐÅÏ¢ IDS ºÅ: 585HT Web of Science ºËÐĺϼ¯ÖÐµÄ "ÒýÓõIJο¼ÎÄÏ×": 22 Web of Science ºËÐĺϼ¯ÖÐµÄ "±»ÒýƵ´Î": 18 |

2Â¥2018-12-06 10:27:01













»Ø¸´´ËÂ¥
harmacology & Pharmacy; Chemistry
40